Opinion · 1 Aug 2024
Conference abstractPublished 13 Oct 2016
Systemic autoimmune diseases
Tehran University of Medical Sciences, Iran
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Multiple sclerosis (MS), a chronic neuro inflammatory autoimmune disease, commonly caused by immune hyper reactivity and characterized by the formation of lesions in the central nervous system (also called plaques), inflammation and the destruction of myelin sheaths of neurons. Peptides are recognized for being highly selective and efficacious and at the same time, relatively safe and well tolerated. Approximately 140 peptides therapeutics are currently being evaluated in clinical trials. Such approaches are multifunctional and cell penetrating peptides, as well as peptide drug conjugates. Before and after presence of selective peptides (IL-2, IL-27, TGFÃ?² and retinoic acid), we will analyze plasma levels and gene expressions (Tbet, RORÃ?³t and FoxP3) of essential cytokines, after induction (MOG) in the C57BL/6 mice using EAE scoring method, splenocyte cell culture, ELISA, flow cytometer and Real Time PCR. RT PCR amplifications will perform to determining the level of IL- 10, IL-2, IL-4, IL-27, IL-35 and TGF-Ã?² as well as in Retinoic acid and IL-12, IFN Ã?³, IL-17, IL-1, IL-6 and IL-23 and mRNA expression levels using the RNA extraction kit. Recent studies showed that a significant decrease in IL-10, IL-2, IL-4, IL-27, IL-35 and TGF-Ã?² as well as in retinoic acid in patients serum but there was no significant difference in the IL-12, IFN Ã?³, IL- 17, IL-1,IL-6 and IL-23 between patients and healthy controls. In this study, we will describe the role of pro inflammatory cytokines in the development of MS. The role of selective peptides on the preventive and therapeutic of MS and will discuss on the experimental test results determining the level of IL-10, IL-2, IL-27, IL-35 and TGF-Ã?² as well as in retinoic acid and IL-12, IFN Ã?³, IL-17, IL-1, IL-6, IL-23 of this disease targeting the cytokines network.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 7 Feb 2023
Systemic Lupus Erythematous (SLE): An Acquired Autoimmune Disease
Research article · 19 Aug 2022
Prevalence of Systemic Lupus Erythematosus and Coexisting Autoimmune Diseases in Puerto Rico in the Context of Hurricane Maria and the COVID-19 Pandemic
Short communication · 23 May 2022
Sicknesses associated with the safe system: Note on autoimmune disease
Commentary · 2021
Systemic autoimmune diseases
More from this journal
The newest in Immunome Research.
Short communication · 29 Dec 2025
Beyond the Surface: Cellular Immune Responses in Uncharted Territories
Commentary · 27 Dec 2025
Stress-Induced Remodeling of Immune Cell Phenotypes
Perspective · 26 Dec 2025
Immune System Dysregulation in Complex Multisystem Disorders
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalImmunome Research
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Zelalem Kiros”

